Literature DB >> 4935398

Infectious disease problems of narcotic addicts.

Charles E Cherubin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4935398     DOI: 10.1001/archinte.1971.00310200145021

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  15 in total

1.  Persistent serratia bacteremia associated with drug abuse.

Authors:  D J Wyler; M G Glickman; A Brewin
Journal:  West J Med       Date:  1975-01

2.  Illicit intravenous drug use and bacterial endocarditis.

Authors:  P D Hoeprich
Journal:  Calif Med       Date:  1973-02

3.  Infectious disease emergencies. Part II: patients presenting with cardiac decompensation or circulatory insufficiency (shock).

Authors: 
Journal:  West J Med       Date:  1976-08

4.  "In vitro" improvement of defective monocyte chemotaxis in intravenous drug abusers after incubation with ascorbic acid.

Authors:  A J Lopez; D G Palomo; J L Castrillon; J L Arellano
Journal:  Klin Wochenschr       Date:  1987-07-01

Review 5.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

Review 6.  Neurological complications of addiction to heroin.

Authors:  R W Richter; J Pearson; B Bruun; Y B Challenor; J C Brust; M M Baden
Journal:  Bull N Y Acad Med       Date:  1973-01

7.  Narcotic abuse: neurological complications in pediatric and adolescent patients.

Authors:  J H French; D M Kaufman
Journal:  J Natl Med Assoc       Date:  1974-09       Impact factor: 1.798

8.  An epidemiologic assessment of heroin use.

Authors:  M H Greene
Journal:  Am J Public Health       Date:  1974-12       Impact factor: 9.308

9.  Race and risk of hepatitis in narcotic addicts.

Authors:  W H Whaley; J T Galambos
Journal:  Am J Dig Dis       Date:  1973-06

10.  AA protein-related renal amyloidosis in drug addicts.

Authors:  S Menchel; D Cohen; E Gross; B Frangione; G Gallo
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.